N4-Methyl-2’-O-methyl-cytidine
N4-Methyl-2’-O-methyl-cytidine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
Product Specifications
CAS Number
[13048-95-8]
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
Nucleoside Antimetabolite/Analog
Type
Oligonucleotides
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/n4-methyl-2-o-methyl-cytidine.html
Solubility
10 mM in DMSO
Smiles
O[C@H]1[C@@H](OC)[C@H](N2C(N=C(NC)C=C2)=O)O[C@@H]1CO
Molecular Formula
C11H17N3O5
Molecular Weight
271.27
Precautions
P261-P280-P302+P352
References & Citations
[1]Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18 (23) :3373-88.
Shipping Conditions
Room temperature
Scientific Category
Oligonucleotides
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
FITC-Linked Monoclonal Antibody to Microtuule Associated Protein 2 (MAP2)
FITC-Linked Monoclonal Antibody to Microtuule Associated Protein 2 (MAP2)
FITC-Linked Monoclonal Antibody to Microtuule Associated Protein 2 (MAP2)
FITC-Linked Monoclonal Antibody to Microtuule Associated Protein 2 (MAP2)